Department of Health and Human Services
National Institutes of Health
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Director's Council of Public Representatives.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such ( printed page 60201) as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Director's Council of Public Representatives.
Date: October 31-November 1, 2000.
Time: October 31, 2000, 8:30 am to 3:30 pm.
Agenda: Among the topics proposed for discussion are: (1) human research protections; (2) informed consent; and (3) medical applications research.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31C, Conference Room 6, Bethesda, MD 20892.
Time: November 1, 2000, 8 am to 10 am.
Agenda: Same as above.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31C, Conference Room 6, Bethesda, MD 20892.
Contact Person: Jennifer E. Gorman, Public Liaison/COPR Coordinator, Office of Communications and Public Liaison, Office of the Director, National Institutes of Health, 9000 Rockville Pike, Building 1, Room 344, Bethesda, MD 20892, (301) 435-4448.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health, HHS)
Dated: October 3, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.